KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nektar Therapeutics (NKTR) Long-Term Investments: 2011-2025

Historic Long-Term Investments for Nektar Therapeutics (NKTR) over the last 9 years, with Sep 2025 value amounting to $4.8 million.

  • Nektar Therapeutics' Long-Term Investments rose 6.61% to $4.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.8 million, marking a year-over-year increase of 6.61%. This contributed to the annual value of $13.9 million for FY2024, which is 46.30% down from last year.
  • Nektar Therapeutics' Long-Term Investments amounted to $4.8 million in Q3 2025, which was down 9.94% from $5.4 million recorded in Q2 2025.
  • In the past 5 years, Nektar Therapeutics' Long-Term Investments ranged from a high of $96.1 million in Q1 2021 and a low of $4.5 million during Q3 2024.
  • Over the past 3 years, Nektar Therapeutics' median Long-Term Investments value was $10.8 million (recorded in 2024), while the average stood at $14.8 million.
  • Per our database at Business Quant, Nektar Therapeutics' Long-Term Investments slumped by 84.45% in 2022 and then increased by 6.61% in 2025.
  • Quarterly analysis of 5 years shows Nektar Therapeutics' Long-Term Investments stood at $64.8 million in 2021, then crashed by 84.45% to $8.9 million in 2022, then reached $25.8 million in 2023, then tumbled by 46.30% to $13.9 million in 2024, then grew by 6.61% to $4.8 million in 2025.
  • Its Long-Term Investments was $4.8 million in Q3 2025, compared to $5.4 million in Q2 2025 and $7.8 million in Q1 2025.